Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
Self-citationThe molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
“Circulating tumor cells represent a heterogeneous group, and the various hybrid phenotypes of EMT from the epithelium (E) to mesenchyme (M) play significant roles in tumor heterogeneity [13, 199].”
BackgroundGerstberger, S., Jiang, Q., & Ganesh, K. (2023) · Cell · doi:10.1016/j.cell.2023.03.003 · Cited by 913
TGF-β signaling in health and disease
Massagué, J., & Sheppard, D. (2023) · Cell · doi:10.1016/j.cell.2023.07.036 · Cited by 890
Self-citationFerroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.819128 · Cited by 763
“EMTlike processes play a significant role in tumor growth and malignant transformation, causing cancer cells to become more aggressive and spread (71, 72).”
BackgroundDynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
“The process is rather gradual and often remains incomplete, termed partial or hybrid EMT (Nieto et al , 2016; Pastushenko & Blanpain, 2019; Yang et al , 2020) (Fig 1B).”
Self-citationLong noncoding RNAs in cancer metastasis
Liu, S. J., Dang, H. X., Lim, D. A., Feng, F. Y., & Maher, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00353-1 · Cited by 648
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xu, X., Zhang, M., Xu, F., & Jiang, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01276-5 · Cited by 588
The current state of the art and future trends in RAS-targeted cancer therapies
Punekar, S. R., Velcheti, V., Neel, B. G., & Wong, K.-K. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00671-9 · Cited by 549
Linking EMT programmes to normal and neoplastic epithelial stem cells
Lambert, A. W., & Weinberg, R. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00332-6 · Cited by 534
Self-citationLüönd, F., Tiede, S., & Christofori, G. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01328-7 · Cited by 427
“This important result is consistent with the notion that EMT is required for local cancer cell invasion, but that MET is required for metastatic outgrowth at the distant site.(47,101,102) In summary, we need to consider that microenvironmental factors at distinct steps of the metastatic cascade could select for certai…”
ResultSelf-citationUnveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
“EMT transition usually happens under the influence of hypoxia, cytokines, or by activation of TGF-β, Notch, hedgehog, and Wnt pathways [181, 182].”
BackgroundTargeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413
“This has been referred to as epithelial cell plasticity (EMP).(125) TGFβ can induce different states of EMP and the cellular response to TGFβ is context-dependent; inflammatory factors, Wnt, Notch, Hippo, and Hedgehog interplay with TGFβ to orchestrate the EMP response.”
BackgroundTherapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
Weng, Z., Zhang, B., Wu, C., Yu, F., Han, B., Li, B., & Li, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01141-y · Cited by 405
Distinct contributions of partial and full EMT to breast cancer malignancy
Lüönd, F., Sugiyama, N., Bill, R., Bornes, L., Hager, C., Tang, F., Santacroce, N., Beisel, C., Ivanek, R., Bürglin, T., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.11.006 · Cited by 391
Self-citationCircRNAs: role in human diseases and potential use as biomarkers
Verduci, L., Tarcitano, E., Strano, S., Yarden, Y., & Blandino, G. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03743-3 · Cited by 374
Metastasis-Initiating Cells and Ecosystems
Massagué, J., & Ganesh, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0010 · Cited by 372
“Each particular epithelial progenitor cell type undergoes its own form of EMT, involving a distinct combination of EMT-TFs and different changes in cell morphology, adhesion, and motility (17).”
BackgroundInfluentialSelf-citationTumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Taki, M., Abiko, K., Ukita, M., Murakami, R., Yamanoi, K., Yamaguchi, K., Hamanishi, J., Baba, T., Matsumura, N., & Mandai, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4459 · Cited by 351
“The EMT International Association (TEMTIA) pronounced the guidelines and definitions of EMT in 2020 to unify the concept of the EMT program because an increasing number of articles on EMT have been published over the past few years and the definition of EMT is becoming vague and controversial (2).”
BackgroundNovel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
Zhang, N., Ng, A. S., Cai, S., Li, Q., Yang, L., & Kerr, D. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00343-0 · Cited by 349
Matrix viscoelasticity controls spatiotemporal tissue organization
Elosegui-Artola, A., Gupta, A., Najibi, A. J., Seo, B. R., Garry, R., Tringides, C. M., de Lázaro, I., Darnell, M., Gu, W., Zhou, Q., et al. (2023) · Nature Materials · doi:10.1038/s41563-022-01400-4 · Cited by 292
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
“To be precise, in case of embryonic development, several sequential cycles of EMT and MET—termed as primary, secondary, and tertiary EMT, are highly organized and carefully orchestrated according to separate biological requirements, resulting in the terminal differentiation of specialized cell types and the organizati…”
BackgroundWang, Y., Xie, Z., Kutschera, E., Adams, J. I., Kadash-Edmondson, K. E., & Xing, Y. (2024) · Nature Protocols · doi:10.1038/s41596-023-00944-2 · Cited by 268
“…analysis of these two cell lines is biologically relevant, as it reveals alternative splicing events that occur during the epithelial–mesenchymal transition (EMT), a fundamental cellular process associated with cell migration, invasion and metastasis in development, fibrosis and cancer 57 .”
Persister cancer cells: Iron addiction and vulnerability to ferroptosis
Rodriguez, R., Schreiber, S. L., & Conrad, M. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.001 · Cited by 267
Cellular Mechanisms of Liver Fibrosis
Acharya, P., Chouhan, K., Weiskirchen, S., & Weiskirchen, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671640 · Cited by 252
Chronic inflammation, cancer development and immunotherapy
Wen, Y., Zhu, Y., Zhang, C., Yang, X., Gao, Y., Li, M., Yang, H., Liu, T., & Tang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1040163 · Cited by 229
“In response to inflammatory factors (TGF-β, IL-1, and IL-1β) secreted by immune cells, tumor cells undergo EMT (Lee, Kang and Cho 2017; Yang et al., 2020).”
BackgroundInfluentialCancer drug resistance induced by EMT: novel therapeutic strategies
De Las Rivas, J., Brozovic, A., Izraely, S., Casas-Pais, A., Witz, I. P., & Figueroa, A. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03063-7 · Cited by 229
“The loss of expression of E-cadherin protein at cell–cell contacts is a hallmark of the EMT, which is accompanied by the downregulation of other epithelial proteins, such as cytokeratins, claudins, and the upregulation of mesenchymal markers, such as N-cadherin, Vimentin or Fibronectin (Nieto et al. 2016; Brabletz et…”
BackgroundInfluentialCancers make their own luck: theories of cancer origins
Jassim, A., Rahrmann, E. P., Simons, B. D., & Gilbertson, R. J. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00602-5 · Cited by 221
Update on Epithelial-Mesenchymal Plasticity in Cancer Progression
Fontana, R., Mestre-Farrera, A., & Yang, J. (2024) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-122423 · Cited by 215
Self-citationLiu, M., Zhang, Y., Yang, J., Zhan, H., Zhou, Z., Jiang, Y., Shi, X., Fan, X., Zhang, J., Luo, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.077 · Cited by 211
Self-citationThe role and regulation of integrins in cell migration and invasion
Chastney, M. R., Kaivola, J., Leppänen, V.-M., & Ivaska, J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00777-1 · Cited by 210
“The EMT programme 157,158 has been viewed predominantly as a binary switch in cancer with cells adopting either an epithelial or a mesenchymal state.”
Bulle, A., & Lim, K.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00341-1 · Cited by 201
Monocyte-endothelial cell interactions in vascular and tissue remodeling
Medrano-Bosch, M., Simón-Codina, B., Jiménez, W., Edelman, E. R., & Melgar-Lesmes, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196033 · Cited by 150
“TGFb1 induces fibroblast differentiation to myofibroblasts or phenomena of epithelial or endothelial to mesenchymal transitions (19, 20) that promote the synthesis of ECM components or tissue inhibitors of”
BackgroundResistance mechanisms to immune checkpoint inhibitors: updated insights
Alsaafeen, B. H., Ali, B. R., & Elkord, E. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02212-7 · Cited by 191
“Epithelial-mesenchymal transition (EMT) is a cellular process during which the phenotypic features of epithelial tumor cells change dynamically toward the mesenchymal phenotype and result in functional changes in cell migration, invasion and metastasis [201].”
Winiarska, A., Knysak, M., Nabrdalik, K., Gumprecht, J., & Stompór, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910822 · Cited by 191
“This scenario contributes to several physiological processes, such as repair from injury and wound healing, and is also operational during embryogenesis; unfortunately, EMT and EndMT may also contribute to tissue scarring and fibrosis as well as promote cancer metastases [27].”
BackgroundMitchel, J. A., Das, A., O’Sullivan, M. J., Stancil, I. T., DeCamp, S. J., Koehler, S., Ocaña, O. H., Butler, J. P., Fredberg, J. J., Nieto, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18841-7 · Cited by 190
Self-citationAnticancer Activity of Propolis and Its Compounds
Forma, E., & Bryś, M. (2021) · Nutrients · doi:10.3390/nu13082594 · Cited by 188
Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family
Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187
Self-citationWang, X., Li, J., Bian, X., Wu, C., Hua, J., Chang, S., Yu, T., Li, H., Li, Y., Hu, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012881118 · Cited by 187
“It is well known that angiogenesis is an important initial step in cancer metastasis (54).”
BackgroundDatta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184
“EMT is a reversible process—EMT followed by a MET is crucial for cancer metastasis [15].”
BackgroundCirculating tumor cells: from new biological insights to clinical practice
Gu, X., Wei, S., & Lv, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01938-6 · Cited by 182
WNT signaling and cancer stemness
Katoh, M., & Katoh, M. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220016 · Cited by 179
The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems
Leggett, S. E., Hruska, A. M., Guo, M., & Wong, I. Y. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00713-2 · Cited by 178
Jin, X., Tang, J., Qiu, X., Nie, X., Ou, S., Wu, G., Zhang, R., & Zhu, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01825-7 · Cited by 176
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Schoutrop, E., Moyano-Galceran, L., Lheureux, S., Mattsson, J., Lehti, K., Dahlstrand, H., & Magalhaes, I. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.027 · Cited by 176
The Mechanics of Mitotic Cell Rounding
Taubenberger, A. V., Baum, B., & Matthews, H. K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00687 · Cited by 176
Decoding leader cells in collective cancer invasion
Mercedes, S. A. V., Bocci, F., Levine, H., Onuchic, J. N., Jolly, M. K., & Wong, P. K. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00376-8 · Cited by 177
Self-citationIdentification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Downes, D. J., Cross, A. R., Hua, P., Roberts, N., Schwessinger, R., Cutler, A. J., Munis, A. M., Brown, J., Mielczarek, O., de Andrea, C. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00955-3 · Cited by 173
“…is challenging due to its diverse and dynamic nature, but can be achieved through a combined assessment of cellular reorganization, an abundance of fibroblasts (which are products of EMT), presence of EMT promoting signaling pathways and co-expression of epithelial and mesenchymal markers 61 .”
Emerging strategies for treating metastasis
Esposito, M., Ganesan, S., & Kang, Y. (2021) · Nature Cancer · doi:10.1038/s43018-021-00181-0 · Cited by 172
Self-citationTGF-β, EMT, and resistance to anti-cancer treatment
Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.004 · Cited by 170
Self-citationSchwab, A., Rao, Z., Zhang, J., Gollowitzer, A., Siebenkäs, K., Bindel, N., D’Avanzo, E., van Roey, R., Hajjaj, Y., Özel, E., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01464-1 · Cited by 169
“Both processes are often triggered by a transient and partial activation of the EMT programme in cancer cells, which is exerted by EMT transcription factors (EMT-TFs), mainly of the Zeb, Snail and bHLH families 1,2 .”
Self-citationMitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma
Raggi, C., Taddei, M. L., Sacco, E., Navari, N., Correnti, M., Piombanti, B., Pastore, M., Campani, C., Pranzini, E., Iorio, J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.12.031 · Cited by 168
Pharmacological targeting of netrin-1 inhibits EMT in cancer
Lengrand, J., Pastushenko, I., Vanuytven, S., Song, Y., Venet, D., Sarate, R. M., Bellina, M., Moers, V., Boinet, A., Sifrim, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06372-2 · Cited by 168
Self-citationHuang, Z., Zhang, Z., Zhou, C., Liu, L., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.144 · Cited by 166
Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
Shen, H., Liu, B., Xu, J., Zhang, B., Wang, Y., Shi, L., & Cai, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01145-8 · Cited by 166
Genome‐wide cooperation of EMT transcription factor ZEB 1 with YAP and AP ‐1 in breast cancer
Feldker, N., Ferrazzi, F., Schuhwerk, H., Widholz, S. A., Guenther, K., Frisch, I., Jakob, K., Kleemann, J., Riegel, D., Bönisch, U., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103209 · Cited by 165
“In addition to ZEB1, EMT can also be induced by other core EMT-transcription factors (EMT-TFs), namely ZEB2, TWIST1 and the two members of the Snail family, which most likely all have non-redundant subfunc-tions (Stemmler et al , 2019; Yang et al , 2020).”
Self-citationTEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Chi, M., Liu, J., Mei, C., Shi, Y., Liu, N., Jiang, X., Liu, C., Xue, N., Hong, H., Xie, J., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02377-3 · Cited by 165
“Epithelial—mesenchymal transition (EMT) is the process of lineage transition between epithelium and mesenchyme, by which the polarized epithelial cells lose their adhesive properties and obtain mesenchymal cell phenotypes [5].”
BackgroundSelf-citationThe Role of IL-6 in Fibrotic Diseases: Molecular and Cellular Mechanisms
Li, Y., Zhao, J., Yin, Y., Li, K., Zhang, C., & Zheng, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75876 · Cited by 164
“Epithelial-mesenchymal transition (EMT) is another biological process induced by IL-6 in fibrotic diseases, in which epithelial cells lose their epithelial phenotypes and gain mesenchymal phenotypes with increased migration and invasion capacities [31].”
BackgroundFunctional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
Pua, L. J. W., Mai, C.-W., Chung, F. F.-L., Khoo, A. S.-B., Leong, C.-O., Lim, W.-M., & Hii, L.-W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031108 · Cited by 164
Ferroptosis: a double-edged sword mediating immune tolerance of cancer
Dang, Q., Sun, Z., Wang, Y., Wang, L., Liu, Z., & Han, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05384-6 · Cited by 165
“Cancer cells with mesenchymal phenotype are highly dependent on GPX4 and are abundant in polyunsaturated fatty acids due to the elevated levels of ZEB1, ELOVL5, and FADS1 expression [58, 106, 107].”
BackgroundInfluentialEpithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells
Eslami‐S, Z., Cortés‐Hernández, L. E., & Alix‐Panabières, C. (2020) · Cells · doi:10.3390/cells9081836 · Cited by 162
“For instance, CTCs can undergo EMT and mesenchymal-to-epithelial transition (MET).”
BackgroundInfluentialCancer Stem Cells—Key Players in Tumor Relapse
Marzagalli, M., Fontana, F., Raimondi, M., & Limonta, P. (2021) · Cancers · doi:10.3390/cancers13030376 · Cited by 161
“The borderline between E/M plasticity and stemness become then evanescent, since the ability to acquire transient biological states within a “plasticity window” has been correlated with stemness [30].”
BackgroundEpithelial–mesenchymal transition in tissue repair and degeneration
Youssef, K. K., & Nieto, M. A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00733-z · Cited by 159
“Epithelial cells lose apicobasal polarity and dismantle established contacts with their neighbouring cells, activate mesenchymal features including invasive properties to spread across the remodelled basal lamina or basal membrane and reorganize adjacent extracellular matrix (ECM) 1,4 .”
InfluentialSelf-citationCao, D., Leong, B. C. S., Messinger, J. D., Kar, D., Ach, T., Yannuzzi, L. A., Freund, K. B., & Curcio, C. A. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.10.34 · Cited by 156
“73 The high OCT visibility of RPE makes it uniquely possible to view these cellular activities in AMD.”
The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation
Haerinck, J., Goossens, S., & Berx, G. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00601-0 · Cited by 156
Self-citationSlow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
Basu, S., Yang, D. Y., Kumar, R., Jeter, C. R., & Tang, D. G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.021 · Cited by 150
Lu, Y., Pan, Q., Gao, W., Pu, Y., Luo, K., He, B., & Gu, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121335 · Cited by 149
Response of cells and tissues to shear stress
Espina, J. A., Cordeiro, M. H., Milivojevic, M. S., Pajić‐Lijaković, I., & Barriga, E. H. (2023) · Journal of Cell Science · doi:10.1242/jcs.260985 · Cited by 148
“Glossary), whereby epithelial cells acquire a mesenchymal phenotype and behavior after the downregulation of epithelial features (Yang et al., 2020).”
Lai, X., Li, Q., Wu, F., Lin, J., Chen, J., Zheng, H., & Guo, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00760 · Cited by 143
“Firstly, enzymes involved in metabolic reprogramming during tumor progression can be used as biomarkers for the therapeutic targeting of cancers (Sun and Yang, 2020).”
BackgroundInfluentialPartial EMT in head and neck cancer biology: a spectrum instead of a switch
Pal, A., Barrett, T. F., Paolini, R. L., Parikh, A. S., & Puram, S. V. (2021) · Oncogene · doi:10.1038/s41388-021-01868-5 · Cited by 143
“The advent of single cell genomics afforded an unprecedented level of resolution in dissecting tumor heterogeneity and the cellular components of the TME [15].”
BackgroundInfluentialRigid tumours contain soft cancer cells
Fuhs, T., Wetzel, F., Fritsch, A. W., Li, X., Stange, R., Pawlizak, S., Kießling, T. R., Morawetz, E. W., Grosser, S., Sauer, F. D., et al. (2022) · Nature Physics · doi:10.1038/s41567-022-01755-0 · Cited by 142
Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues
Braun, A., Anders, H., Gudermann, T. W., & Mammadova‐Bach, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.665534 · Cited by 142
How important is EMT for cancer metastasis?
Celià-Terrassa, T., & Kang, Y. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002487 · Cited by 142
“…and reproducibility in EMT research, experts in the field have recently reached consensus on how to define and characterize EMT, with a strong emphasis on the characterization of cellular properties with comprehensive molecular analysis, rather than relying on a few readily monitored markers [22].”
BackgroundSelf-citationRoles of mitochondria in the hallmarks of metastasis
Scheid, A. D., Beadnell, T. C., & Welch, D. R. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01125-8 · Cited by 137
Redox signaling at the crossroads of human health and disease
Zuo, J., Zhang, Z., Luo, M., Zhou, L., Nice, E. C., Zhang, W., Wang, C., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.127 · Cited by 137
Oulis, C. J., Vadiakas, G., Ekonomides, J., & Dratsa, J. (1994) · PubMed · Cited by 137
Interplay between tumor microenvironment and partial EMT as the driver of tumor progression
Aggarwal, V., Montoya, C. A., Donnenberg, V. S., & Sant, S. (2021) · iScience · doi:10.1016/j.isci.2021.102113 · Cited by 135
Li, S., & Huang, Y. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02669-8 · Cited by 135
“Previous works have shown ferroptosis sensitivity is significantly correlated with tumor gene mutations, such as RAS [40], TP53 mutation [41], HIF mutation, stress response pathways [42], epithelialmesenchymal-transformation(EMT) [43] and other signaling pathways.”
BackgroundTumor metastasis: Mechanistic insights and therapeutic interventions
Liu, M., Yang, J., Xu, B.-S., & Zhang, X. (2021) · MedComm · doi:10.1002/mco2.100 · Cited by 136
Self-citationHolme, J. A., Vondráček, J., Machala, M., Lagadic‐Gossmann, D., Vogel, C. F. A., Ferrec, E. L., Sparfel, L., & Øvrevik, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115801 · Cited by 135
Zhang, Y., Donaher, J. L., Das, S., Li, X., Reinhardt, F., Krall, J. A., Lambert, A. W., Thiru, P., Keys, H. R., Khan, M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00877-0 · Cited by 133
Self-citationYoussef, K. K., Narwade, N. P., Arcas, A., Márquez-Galera, Á., Jiménez-Castaño, R., López-Blau, C., Fazilaty, H., García-Gutierrez, D., Cano, A., Galcerán, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00839-5 · Cited by 133
“EMT is not a binary process or a single program, as it implies the generation of intermediate hybrid epithelial–mesenchymal (E/M) states that, often, never reach the full mesenchymal state 4,5 .”
Self-citationEndocytosis in the context-dependent regulation of individual and collective cell properties
Sigismund, S., Lanzetti, L., Scita, G., & Di Fiore, P. P. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00375-5 · Cited by 132
Cancer metastasis: Molecular mechanisms and clinical perspectives
Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 132
The Role of Adipokines in Tumor Progression and Its Association with Obesity
Kim, J., Kim, J. H., & Lee, Y. J. (2024) · Biomedicines · doi:10.3390/biomedicines12010097 · Cited by 133
“EMT is associated with alterations in the intracellular cytoskeleton and extracellular matrix (ECM) degradation, leading to local invasion and subsequent dissemination into distant tissues [120].”
BackgroundEpithelial-mesenchymal transition
Zhang, C. X., Huang, R. Y., Sheng, G., & Thiery, J. P. (2025) · Cell · doi:10.1016/j.cell.2025.08.033 · Cited by 134
Self-citationComba, A., Faisal, S. M., Dunn, P., Argento, A. E., Hollon, T. C., Al‐Holou, W. N., Varela, M. L., Zamler, D. B., Quass, G. L., Apostolides, P. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31340-1 · Cited by 131
The role of MET in chemotherapy resistance
Wood, G. E., Hockings, H., Hilton, D. M., & Kermorgant, S. (2021) · Oncogene · doi:10.1038/s41388-020-01577-5 · Cited by 127
NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype
Oh, A., Pardo, M. R., Rodriguez, A., Yu, C., Nguyen, L., Liang, O. D., Chorzalska, A. D., & Dubielecka, P. M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01207-z · Cited by 129
“Given the heterogeneity of EMT states and pleiotropy of observed intermediate phenotypes it has become clear that EMT state should be defined based on collective features including activity of core EMT TFs as well as morphological and cytological phenotypes [4].”
BackgroundEMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
Genna, A., Vanwynsberghe, A. M., Villard, A. V., Pottier, C., Ancel, J., Polette, M., & Gilles, C. (2020) · Cancers · doi:10.3390/cancers12061632 · Cited by 126
Kayalar, Ö., Rajabi, H., Konyalılar, N., Mortazavi, D., Aksoy, G. T., Wang, J., & Bayram, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324552 · Cited by 122
Intracellular bacteria in cancer—prospects and debates
Schorr, L., Mathies, M., Elinav, E., & Puschhof, J. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00446-9 · Cited by 120
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
Zhang, J., ten Dijke, P., Wuhrer, M., & Zhang, T. (2020) · Protein & Cell · doi:10.1007/s13238-020-00741-7 · Cited by 117
“This plasticity refers to as partial EMT, hybrid E/M status, a metastable EMT state, EMT continuum and EMTspectrum (Yang et al., 2020).”
BackgroundThe Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
Abaurrea, A., Araujo, A. M., & Caffarel, M. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158334 · Cited by 117
“Epithelial–mesenchymal transition (EMT) is a dynamic process in which epithelial cells reorganize their cytoskeleton, lose apical–basal polarity, cell–cell adhesions and acquire mesenchymal phenotypes with increased migration and invasion capacities [1].”
BackgroundInfluentialWalking the tight wire between cell adhesion and WNT signalling: a balancing act for β-catenin
van der Wal, T., & van Amerongen, R. (2020) · Open Biology · doi:10.1098/rsob.200267 · Cited by 115
“An international consortium of researchers recently published guidelines to investigate and define the EMT process, and its many intermediate phenotypes, based on a combination of molecular markers and cellular properties [147].”
Zhang, J., Hu, Z., Horta, C. A., & Yang, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.002 · Cited by 114
“Of note, the EMT-TFs regulate the transcription of each other and cooperate to orchestrate EMT progression[5,26].”
BackgroundSelf-citationUnderstanding and targeting prostate cancer cell heterogeneity and plasticity
Tang, D. G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.001 · Cited by 112
Yonesaka, K., Tanizaki, J., Maenishi, O., Haratani, K., Kawakami, H., Tanaka, K., Hayashi, H., Sakai, K., Chiba, Y., Tsuya, A., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3359 · Cited by 110
“Therefore, we examined the relationship between the HER3 mRNA expression level and the expression level of the core EMT transcription factors (TF), such as mRNA including Zeb1/2, Twist1, and Snai1/2 (29).”
BackgroundKhalili‐Tanha, G., Radisky, E. S., Radisky, D. C., & Shoari, A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06447-w · Cited by 112
“In embryonic development, exemplified by gastrulation and neural crest cell migration, the transient loss of epithelial characteristics permits cell delamination and differentiation into diverse lineages [2, 27].”
Influential
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.